Olfaction in the psychosis prodrome: Electrophysiological and behavioral measures of odor detection

International Journal of Psychophysiology

Volumn 90, Issue 2, 2013, Pages 190-206

  Kayser, Jürgen ^a,b   Tenke, Craig E ^a,b   Kroppmann, Christopher J ^b   Alschuler, Daniel M ^b   Ben David, Shelly ^b   Fekri, Shiva ^b   Bruder, Gerard E ^a,b   Corcoran, Cheryl M ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Clinical high risk (CHR); Current source density (CSD); Event related potentials (ERP); Negative symptoms; Olfaction; Principal components analysis (PCA); Prodrome; Schizophrenia

Indexed keywords

HYDROGEN SULFIDE;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; NEGATIVE SYNDROME; ODOR; OLFACTOMETER; OLFACTORY DISCRIMINATION; PRODROMAL SYMPTOM; PSYCHOSIS; SCHIZOPHRENIA; SENSORY STIMULATION; SMELLING; SMELLING DISORDER; TASK PERFORMANCE; WAVEFORM;

CLINICAL HIGH-RISK (CHR); CURRENT SOURCE DENSITY (CSD); EVENT-RELATED POTENTIALS (ERP); NEGATIVE SYMPTOMS; OLFACTION; PRINCIPAL COMPONENTS ANALYSIS (PCA); PRODROME; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BRAIN MAPPING; CHILD; CROSS-SECTIONAL STUDIES; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; ODORS; OLFACTION DISORDERS; PSYCHOTIC DISORDERS; REACTION TIME; SENSITIVITY AND SPECIFICITY; SMELL; TASTE THRESHOLD; YOUNG ADULT;

EID: 84886948603     PISSN: 01678760     EISSN: 18727697     Source Type: Journal    
DOI: 10.1016/j.ijpsycho.2013.07.003     Document Type: Article

References (131)

1. Amminger G.P., Leicester S., Yung A.R., Phillips L.J., Berger G.E., Francey S.M., Yuen H.P., McGorry P.D. Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophrenia Research 2006, 84(1):67-76.
2. Anderson A.K., Christoff K., Stappen I., Panitz D., Ghahremani D.G., Glover G., Gabrieli J.D., Sobel N. Dissociated neural representations of intensity and valence in human olfaction. Nature Neuroscience 2003, 6(2):196-202.
3. Atanasova B., Graux J., El Hage W., Hommet C., Camus V., Belzung C. Olfaction: a potential cognitive marker of psychiatric disorders. Neuroscience and Biobehavioral Reviews 2008, 32(7):1315-1325.
4. Atkinson R.J., Michie P.T., Schall U. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biological Psychiatry 2012, 71(2):98-104.
5. Barresi M., Ciurleo R., Giacoppo S., Foti Cuzzola V., Celi D., Bramanti P., Marino S. Evaluation of olfactory dysfunction in neurodegenerative diseases. Journal of Neurological Sciences 2012, 323(1-2):16-24.
6. Beauducel A., Debener S. Misallocation of variance in event-related potentials: simulation studies on the effects of test power, topography, and baseline-to-peak versus principal component quantifications. Journal of Neuroscience Methods 2003, 124(1):103-112.
7. Beauducel A., Debener S., Brocke B., Kayser J. On the reliability of augmenting/reducing: peak amplitudes and principal components analysis of auditory evoked potentials. Journal of Psychophysiology 2000, 14(4):226-240.
8. Becker E., Hummel T., Piel E., Pauli E., Kobal G., Hautzinger M. Olfactory event-related potentials in psychosis-prone subjects. International Journal of Psychophysiology 1993, 15(1):51-58.
9. Bodatsch M., Ruhrmann S., Wagner M., Müller R., Schultze Lutter F., Frommann I., Brinkmeyer J., Gaebel W., Maier W., Klosterkötter J., Brockhaus-Dumke A. Prediction of psychosis by mismatch negativity. Biological Psychiatry 2011, 69(10):959-966.
10. Brewer W.J., Pantelis C., Anderson V., Velakoulis D., Singh B., Copolov D.L., McGorry P.D. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. The American Journal of Psychiatry 2001, 158(1):107-115.
11. Brewer W.J., Wood S.J., McGorry P.D., Francey S.M., Phillips L.J., Yung A.R., Anderson V., Copolov D.L., Singh B., Velakoulis D., Pantelis C. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. The American Journal of Psychiatry 2003, 160(10):1790-1794.
12. Brewer W.J., Francey S.M., Wood S.J., Jackson H.J., Pantelis C., Phillips L.J., Yung A.R., Anderson V.A., McGorry P.D. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. The American Journal of Psychiatry 2005, 162(1):71-78.
13. Brewer W.J., Wood S.J., Phillips L.J., Francey S.M., Pantelis C., Yung A.R., Cornblatt B., McGorry P.D. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophrenia Bulletin 2006, 32(3):538-555.
14. Bruder G.E., Kroppmann C.J., Kayser J., Stewart J.W., McGrath P.J., Tenke C.E. Reduced brain responses to novel sounds in depression: P3 findings in a novelty oddball task. Psychiatry Research 2009, 170(2-3):218-223.
15. Buron E., Bulbena A. Olfaction in affective and anxiety disorders: a review of the literature. Psychopathology 2013, 46(2):63-74.
16. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 2008, 65(1):28-37.
17. Chapman R.M., McCrary J.W. EP component identification and measurement by principal components analysis. Brain and Cognition 1995, 27(3):288-310.
18. Cohen A.S., Brown L.A., Auster T.L. Olfaction, "olfiction", and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity. Schizophrenia Research 2012, 135(1-3):152-157.
19. Cohen A.S., Brown L.A., Auster T.L. Clarifying the nature of olfaction deficits in the schizophrenia-prone: "clinical high-risk state" versus "vulnerability". Schizophrenia Research 2012, 139(1-3):262-263.
20. Coleman E., Goetz R.R., Leitman D., Yale S., Stanford A., Gorman J.M., Malaspina D. Odor identification impairments in schizophrenia: relationship with demographic measures, clinical variables, and diagnostic subtypes. CNS Spectrums 2002, 7(1):43-48.
21. Corcoran C., Whitaker A., Coleman E., Fried J., Feldman J., Goudsmit N., Malaspina D. Olfactory deficits, cognition and negative symptoms in early onset psychosis. Schizophrenia Research 2005, 80(2-3):283-293.
22. Corcoran C.M., First M.B., Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophrenia Research 2010, 120(1-3):16-22.
23. Corcoran C.M., Kimhy D., Parrilla Escobar M.A., Cressman V.L., Stanford A.D., Thompson J., David S.B., Crumbley A., Schobel S., Moore H., Malaspina D. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine 2011, 41(2):251-261.
24. Crespo-Facorro B., Paradiso S., Andreasen N.C., O'Leary D.S., Watkins G.L., Ponto L.L., Hichwa R.D. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. J.A.M.A. 2001, 286(4):427-435.
25. Croy I., Lange K., Krone F., Negoias S., Seo H.S., Hummel T. Comparison between odor thresholds for phenyl ethyl alcohol and butanol. Chemical Senses 2009, 34(6):523-527.
26. BMDP Statistical Software Manual: To Accompany the 7.0 Software Release 1992, University of California Press, Berkeley, CA. W.J. Dixon (Ed.).
27. Donchin E., Heffley E.F. Multivariate analysis of event-related potential data: a tutorial review. Multidisciplinary Perspectives in Event-Related Brain Potential Research. Proceedings of the Fourth International Congress on Event-Related Slow Potentials of the Brain (EPIC IV), Hendersonville, NC, April 4-10, 1976 1978, 555-572. The Office, Washington, DC. D.A. Otto (Ed.).
28. Doty R.L., Brugger W.E., Jurs P.C., Orndorff M.A., Snyder P.J., Lowry L.D. Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiology and Behavior 1978, 20(2):175-185.
29. Doty R.L., Shaman P., Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiology and Behavior 1984, 32(3):489-502.
30. Dudova I., Vodicka J., Havlovicova M., Sedlacek Z., Urbanek T., Hrdlicka M. Odor detection threshold, but not odor identification, is impaired in children with autism. European Child & Adolescent Psychiatry 2011, 20(7):333-340.
31. Egerton A., Chaddock C.A., Winton Brown T.T., Bloomfield M.A., Bhattacharyya S., Allen P., McGuire P.K., Howes O.D. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biological Psychiatry 2013, (Jan 8, Epub ahead of print). 10.1016/j.biopsych.2012.11.017.
32. Evans W.J., Kobal G., Lorig T.S., Prah J.D. Suggestions for collection and reporting of chemosensory (olfactory) event-related potentials. Chemical Senses 1993, 18(6):751-756.
33. Ford J.M. Schizophrenia: the broken P300 and beyond. Psychophysiology 1999, 36(6):667-682.
34. Frommann I., Brinkmeyer J., Ruhrmann S., Hack E., Brockhaus-Dumke A., Bechdolf A., Wölwer W., Klosterkötter J., Maier W., Wagner M. Auditory P300 in individuals clinically at risk for psychosis. International Journal of Psychophysiology 2008, 70(3):192-205.
35. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry 2012, 69(3):220-229.
36. Fusar-Poli P., McGuire P., Borgwardt S. Mapping prodromal psychosis: a critical review of neuroimaging studies. European Psychiatry 2012, 27(3):181-191.
37. Gee D.G., Cannon T.D. Prediction of conversion to psychosis: review and future directions. Revista Brasileira de Psiquiatria 2011, 332:129-142.
38. Good K.P., Whitehorn D., Rui Q., Milliken H., Kopala L.C. Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms. The American Journal of Psychiatry 2006, 163(5):932-933.
39. Häfner H., Maurer K., Löffler W., ander Heiden W., Hambrecht M., Schultze-Lutter F. Modeling the early course of schizophrenia. Schizophrenia Bulletin 2003, 29(2):325-340.
40. Haroun N., Dunn L., Haroun A., Cadenhead K.S. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin 2006, 32(1):166-178.
41. Hawkins K.A., Addington J., Keefe R.S., Christensen B., Perkins D.O., Zipurksy R., Woods S.W., Miller T.J., Marquez E., Breier A., McGlashan T.H. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research 2004, 67(2-3):115-122.
42. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophrenia Bulletin 2009, 35(3):549-562.
43. 18F]-DOPA PET imaging study. The American Journal of Psychiatry 2011, 168(12):1311-1317.
44. Huart C., Legrain V., Hummel T., Rombaux P., Mouraux A. Time-frequency analysis of chemosensory event-related potentials to characterize the cortical representation of odors in humans. PLoS One 2012, 7(3):33221.
45. Hummel T., Sekinger B., Wolf S.R., Pauli E., Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chemical Senses 1997, 22(1):39-52.
46. Hurwitz T., Kopala L., Clark C., Jones B. Olfactory deficits in schizophrenia. Biological Psychiatry 1988, 23(2):123-128.
47. Jacquot L., Monnin J., Brand G. Unconscious odor detection could not be due to odor itself. Brain Research 2004, (1-2):51-54.
48. Javitt D.C., Spencer K.M., Thaker G.K., Winterer G., Hajos M. Neurophysiological biomarkers for drug development in schizophrenia. Nature Reviews Drug Discovery 2008, 7(1):68-83.
49. Jurcak V., Tsuzuki D., Dan I. 10/20, 10/10, and 10/5 systems revisited: their validity as relative head-surface-based positioning systems. NeuroImage 2007, 34(4):1600-1611.
50. Kamath V., Turetsky B.I., Calkins M.E., Kohler C.G., Conroy C.G., Borgmann Winter K., Gatto D.E., Gur R.E., Moberg P.J. Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. The World Journal of Biological Psychiatry 2011, (Nov 10, Epub ahead of print). 10.3109/15622975.2011.615862.
51. Kamath V., Moberg P.J., Calkins M.E., Borgmann-Winter K., Conroy C.G., Gur R.E., Kohler C.G., Turetsky B.I. An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis. Schizophrenia Research 2012, 138(2-3):280-284.
52. Kayser J. Current Source Density (CSD) Interpolation Using Spherical Splines - CSD Toolbox (Version 1.1) 2009, Division of Cognitive Neuroscience, New York State Psychiatric Institute, (http://psychophysiology.cpmc.columbia.edu/Software/CSDtoolbox).
53. Kayser J., Tenke C.E. Optimizing PCA methodology for ERP component identification and measurement: theoretical rationale and empirical evaluation. Clinical Neurophysiology 2003, 114(12):2307-2325.
54. Kayser J., Tenke C.E. Trusting in or breaking with convention: towards a renaissance of principal components analysis in electrophysiology. Clinical Neurophysiology 2005, 116(8):1747-1753.
55. Kayser J., Tenke C.E. Principal components analysis of Laplacian waveforms as a generic method for identifying ERP generator patterns: I. Evaluation with auditory oddball tasks. Clinical Neurophysiology 2006, 117(2):348-368.
56. Kayser J., Tenke C.E. Principal components analysis of Laplacian waveforms as a generic method for identifying ERP generator patterns: II. Adequacy of low-density estimates. Clinical Neurophysiology 2006, 117(2):369-380.
57. Kayser J., Tenke C.E. Consensus on PCA for ERP data, and sensibility of unrestricted solutions. Clinical Neurophysiology 2006, 117(3):703-707.
58. Kayser J., Tenke C.E. Electrical distance as a reference-free measure for identifying artifacts in multichannel electroencephalogram (EEG) recordings. Psychophysiology 2006, 43:S51. (available at http://psychophysiology.cpmc.columbia.edu/mmedia/SPR2006/ElecDistArti.pdf).
59. Kayser J., Tenke C.E. In search of the Rosetta Stone for scalp EEG: converging on reference-free techniques. Clinical Neurophysiology 2010, 121(12):1973-1975.
60. Kayser J., Tenke C., Nordby H., Hammerborg D., Hugdahl K., Erdmann G. Event-related potential (ERP) asymmetries to emotional stimuli in a visual half-field paradigm. Psychophysiology 1997, 34(4):414-426.
61. Kayser J., Tenke C.E., Bruder G.E. Dissociation of brain ERP topographies for tonal and phonetic oddball tasks. Psychophysiology 1998, 35(5):576-590.
62. Kayser J., Tenke C.E., Gates N.A., Bruder G.E. Reference-independent ERP old/new effects of auditory and visual word recognition memory: joint extraction of stimulus- and response-locked neuronal generator patterns. Psychophysiology 2007, 44(6):949-967.
63. Kayser J., Tenke C.E., Malaspina D., Kroppmann C.J., Schaller J.D., Deptula A., Gates N.A., Harkavy-Friedman J.M., Gil R., Bruder G.E. Neuronal generator patterns of olfactory event-related brain potentials in schizophrenia. Psychophysiology 2010, 47(6):1075-1086.
64. Kayser J., Tenke C.E., Kroppmann C.J., Alschuler D.M., Fekri S., Stewart J.W., McGrath P.J., Turetsky B.I., Bruder G.E. Effects of odor valence and arousal on event-related potentials (ERPs) in healthy adults and depressed patients. Biological Psychiatry 2012, 71(8):78S-79S. (available at http://psychophysiology.cpmc.columbia.edu/mmedia/SoBP2012/oERPemot.pdf).
65. Kayser J., Tenke C.E., Kroppmann C.J., Alschuler D.M., Fekri S., Ben-David S., Corcoran C.M., Bruder G.E. Auditory Event-related Potentials and Alpha Oscillations in the Psychosis Prodrome: Neuronal Generator Patterns During a Novelty Oddball Task 2013, (submitted for publication).
66. Keselman H.J. Testing treatment effects in repeated measures designs: an update for psychophysiological researchers. Psychophysiology 1998, 35(4):470-478.
67. Kjelvik G., Evensmoen H.R., Brezova V., Haberg A.K. The human brain representation of odor identification. Journal of Neurophysiology 2012, 108(2):645-657.
68. Kobal G., Klimek L., Wolfensberger M., Gudziol H., Temmel A., Owen C.M., Seeber H., Pauli E., Hummel T. Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. European Archives of Oto-Rhino-Laryngology 2000, 257(4):205-211.
69. Koh Y., Shin K.S., Kim J.S., Choi J.S., Kang D.H., Jang J.H., Cho K.H., O'Donnell B.F., Chung C.K., Kwon J.S. An MEG study of alpha modulation in patients with schizophrenia and in subjects at high risk of developing psychosis. Schizophrenia Research 2011, 126(1-3):36-42.
70. Kohler C.G., Barrett F.S., Gur R.C., Turetsky B.I., Moberg P.J. Association between facial emotion recognition and odor identification in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences 2007, 19(2):128-131.
71. Kopala L.C., Good K.P., Morrison K., Bassett A.S., Alda M., Honer W.G. Impaired olfactory identification in relatives of patients with familial schizophrenia. The American Journal of Psychiatry 2001, 158(8):1286-1290.
72. Lencz T., Smith C.W., McLaughlin D., Auther A., Nakayama E., Hovey L., Cornblatt B.A. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biological Psychiatry 2006, 59(9):863-871.
73. Lorig T.S. The application of electroencephalographic techniques to the study of human olfaction: a review and tutorial. International Journal of Psychophysiology 2000, 36(2):91-104.
74. Malaspina D., Coleman E. Olfaction and social drive in schizophrenia. Archives of General Psychiatry 2003, 60(6):578-584.
75. Malaspina D., Perera G.M., Lignelli A., Marshall R.S., Esser P.D., Storer S., Furman V., Wray A.D., Coleman E., Gorman J.M., Van Heertum R.L. SPECT imaging of odor identification in schizophrenia. Psychiatry Research 1998, 82(1):53-61.
76. Maris E. Randomization tests for ERP topographies and whole spatiotemporal data matrices. Psychophysiology 2004, 41(1):142-151.
77. Martzke J.S., Kopala L.C., Good K.P. Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biological Psychiatry 1997, 42(8):721-732.
78. Mathalon D.H., Ford J.M., Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biological Psychiatry 2000, 47(5):434-449.
79. Mewhort D.J.K., Johns B.T., Kelly M. Applying the permutation test to factorial designs. Behavior Research Methods 2010, 42(2):366-372.
80. Miller T.J., McGlashan T.H., Woods S.W., Stein K., Driesen N., Corcoran C.M., Hoffman R., Davidson L. Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly 1999, 70(4):273-287.
81. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interarater reliability, and training to reliability. Schizophrenia Bulletin 2003, 29(4):703-715.
82. Moberg P.J., Turetsky B.I. Scent of a disorder: olfactory functioning in schizophrenia. Current Psychiatry Reports 2003, 5(4):311-319.
83. Moberg P.J., Agrin R., Gur R.E., Gur R.C., Turetsky B.I., Doty R.L. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology 1999, 21(3):325-340.
84. Moberg P.J., Arnold S.E., Doty R.L., Kohler C., Kanes S., Seigel S., Gur R.E., Turetsky B.I. Impairment of odor hedonics in men with schizophrenia. The American Journal of Psychiatry 2003, 160(10):1784-1789.
85. Moberg P.J., Arnold S.E., Doty R.L., Gur R.E., Balderston C.C., Roalf D.R., Gur R.C., Kohler C.G., Kanes S.J., Siegel S.J., Turetsky B.I. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. Journal of Clinical and Experimental Neuropsychology 2006, 28(8):1444-1461.
86. NeuroScan Inc. SCAN Manual II Version 3.0 1993, Author, Herndon, VA.
87. NeuroScan Inc. SCAN 4.3 - Vol. II. EDIT 4.3 - Offline Analysis of Acquired Data (Document Number 2203, Revision D) 2003, Compumedics Neuroscan, El Paso, TX.
88. Nordin S., Lötsch J., Murphy C., Hummel T., Kobal G. Circadian rhythm and desensitization in chemosensory event-related potentials in response to odorous and painful stimuli. Psychophysiology 2003, 40(4):612-619.
89. Nunez P.L., Srinivasan R. Electric Fields of the Brain: the Neurophysics of EEG 2006, Oxford University Press, New York.
90. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9(1):97-113.
91. Olofsson J.K., Nordin S. Gender differences in chemosensory perception and event-related potentials. Chemical Senses 2004, 29(7):629-637.
92. Olofsson J.K., Broman D.A., Gilbert P.E., Dean P., Nordin S., Murphy C. Laterality of the olfactory event-related potential response. Chemical Senses 2006, 31(7):699-704.
93. Olofsson J.K., Ericsson E., Nordin S. Comparison of chemosensory, auditory and visual event-related potential amplitudes. Scandinavian Journal of Psychology 2008, 49(3):231-237.
94. Pause B.M., Krauel K. Chemosensory event-related potentials (CSERP) as a key to the psychology of odors. International Journal of Psychophysiology 2000, 36(2):105-122.
95. Perrin F., Pernier J., Bertrand O., Echallier J.F. Spherical splines for scalp potential and current density mapping [Corrigenda EEG 02274, EEG Clin. Neurophysiol, 1990, 76, 565]. Electroencephalography and Clinical Neurophysiology 1989, 72(2):184-187.
96. Piskulic D., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., McGlashan T.H. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Research 2012, 196(2-3):220-224.
97. Pivik R.T., Broughton R.J., Coppola R., Davidson R.J., Fox N., Nuwer M.R. Guidelines for the recording and quantitative analysis of electroencephalographic activity in research contexts. Psychophysiology 1993, 30(6):547-558.
98. Purdon S.E., Flor-Henry P. Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia. Schizophrenia Research 2000, 44(3):221-232.
99. Roalf D.R., Turetsky B.I., Owzar K., Balderston C.C., Johnson S.C., Brensinger C.M., Gur R.E., Siegel S.J., Moberg P.J. Unirhinal olfactory function in schizophrenia patients and first-degree relatives. The Journal of Neuropsychiatry and Clinical Neurosciences 2006, 18(3):389-396.
100. Rupp C.I. Olfactory function and schizophrenia: an update. Current Opinion in Psychiatry 2010, 23(2):97-102.
101. Rupp C.I., Fleischhacker W.W., Kemmler G., Kremser C., Bilder R.M., Mechtcheriakov S., Szeszko P.R., Walch T., Scholtz A.W., Klimbacher M., Maier C., Albrecht G., Lechner Schoner T., Felber S., Hinterhuber H. Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophrenia. Schizophrenia Research 2005, 74(2-3):149-161.
102. Schneider F., Habel U., Reske M., Toni I., Falkai P., Shah N.J. Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Research Neuroimaging 2007, 155(2):103-112.
103. Schecklmann M., Schwenck C., Taurines R., Freitag C., Warnke A., Gerlach M., Romanos M. A systematic review on olfaction in child and adolescent psychiatric disorders. Journal of Neural Transmission 2013, 120(1):121-130.
104. Seidman L.J., Talbot N.L., Kalinowski A.G., McCarley R.W., Faraone S.V., Kremen W.S., Pepple J.R., Tsuang M.T. Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia. Olfactory identification and Wisconsin Card Sorting performance. Schizophrenia Research 1991, 6(1):55-65.
105. Seidman L.J., Goldstein J.M., Goodman J.M., Koren D., Turner W.M., Faraone S.V., Tsuang M.T. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relationship to attention and verbal ability. Biological Psychiatry 1997, 42(2):104-115.
106. Seubert J., Freiherr J., Djordjevic J., Lundström J.N. Statistical localization of human olfactory cortex. NeuroImage 2013, 66:333-342.
107. Shaikh M., Valmaggia L., Broome M.R., Dutt A., Lappin J., Day F., Woolley J., Tabraham P., Walshe M., Johns L., Fusar-Poli P., Howes O., Murray R.M., McGuire P., Bramon E. Reduced mismatch negativity predates the onset of psychosis. Schizophrenia Research 2012, 134(1):42-48.
108. Silveira-Moriyama L., de Jesus Carvalho M., Katzenschlager R., Petrie A., Ranvaud R., Barbosa E.R., Lees A.J. The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil. Movement Disorders 2008, 23(16):2328-2334.
109. Simon A.E., Velthorst E., Nieman D.H., Linszen D., de Umbricht D., Haan L. Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophrenia Research 2011, 132(1):8-17.
110. Sinai A., Pratt H. Electrophysiological evidence for priming in response to words and pseudowords in first and second language. Brain and Language 2002, 80(2):240-252.
111. Snodgrass J.G., Corwin J. Pragmatics of measuring recognition memory: applications to dementia and amnesia. Journal of Experimental Psychology. General 1988, 117(1):34-50.
112. Stuck B.A., Frey S., Freiburg C., Hormann K., Zahnert T., Hummel T. Chemosensory event-related potentials in relation to side of stimulation, age, sex, and stimulus concentration. Clinical Neurophysiology 2006, 117(6):1367-1375.
113. Tenke C.E., Kayser J. A convenient method for detecting electrolyte bridges in multichannel electroencephalogram and event-related potential recordings. Clinical Neurophysiology 2001, 112(3):545-550.
114. Tenke C.E., Kayser J. Generator localization by current source density (CSD): implications of volume conduction and field closure at intracranial and scalp resolutions. Clinical Neurophysiology 2012, 123(12):2328-2345.
115. Tenke C.E., Kayser J., Shankman S.A., Griggs C.B., Leite P., Stewart J.W., Bruder G.E. Hemispatial PCA dissociates temporal from parietal ERP generator patterns: CSD components in healthy adults and depressed patients during a dichotic oddball task. International Journal of Psychophysiology 2008, 67(1):1-16.
116. Tenke C.E., Kayser J., Stewart J.W., Bruder G.E. Novelty P3 reductions in depression: characterization using principal components analysis (PCA) of current source density (CSD) waveforms. Psychophysiology 2010, 47(1):133-146.
117. Tenke C.E., Kayser J., Manna C.G., Fekri S., Kroppmann C.J., Schaller J.D., Alschuler D.M., Stewart J.W., McGrath P.J., Bruder G.E. Current source density measures of electroencephalographic alpha predict antidepressant treatment response. Biological Psychiatry 2011, 70(4):388-394.
118. Turetsky B.I., Moberg P.J., Owzar K., Johnson S.C., Doty R.L., Gur R.E. Physiologic impairment of olfactory stimulus processing in schizophrenia. Biological Psychiatry 2003, 53(5):403-411.
119. Turetsky B.I., Moberg P.J., Roalf D.R., Arnold S.E., Gur R.E. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Archives of General Psychiatry 2003, 60(12):1193-1200.
120. Turetsky B.I., Moberg P.J., Arnold S.E., Doty R.L., Gur R.E. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. The American Journal of Psychiatry 2003, 160(4):703-708.
121. Turetsky B.I., Kohler C.G., Gur R.E., Moberg P.J. Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophrenia Research 2008, 102(1-3):220-229.
122. Turetsky B.I., Kamath V., Calkins M.E., Brewer W.J., Wood S.J., Pantelis C., Seidman L.J., Malaspina D., Good K.P., Kopala L.C., Moberg P.J. Olfaction and schizophrenia clinical risk status: just the facts. Schizophrenia Research 2012, 139(1-3):2-3.
123. van Boxtel G.J.M. Computational and statistical methods for analyzing event-related potential data. Behavior Research Methods, Instruments, & Computers 1998, 30(1):87-102.
124. van der Stelt O., Lieberman J.A., Belger A. Auditory P300 in high-risk, recent-onset and chronic schizophrenia. Schizophrenia Research 2005, 77(2-3):309-320.
125. van Tricht M.J., Nieman D.H., Koelman J.H., vander Meer J.N., Bour L.J., de Haan L., Linszen D.H. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biological Psychiatry 2010, 68(7):642-648.
126. Velthorst E., Nieman D.H., Becker H.E., vande Fliert R., Dingemans P.M., Klaassen R., de Haan L., van Amelsvoort T., Linszen D.H. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophrenia Research 2009, 109(1-3):60-65.
127. Wang L., Walker V.E., Sardi H., Fraser C., Jacob T.J. The correlation between physiological and psychological responses to odour stimulation in human subjects. Clinical Neurophysiology 2002, 113(4):542-551.
128. Winterer G., Coppola R., Egan M.F., Goldberg T.E., Weinberger D.R. Functional and effective frontotemporal connectivity and genetic risk for schizophrenia. Biological Psychiatry 2003, 54(11):1181-1192.
129. Wölwer W., Brinkmeyer J., Stroth S., Streit M., Bechdolf A., Ruhrmann S., Wagner M., Gaebel W. Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia. Schizophrenia Bulletin 2012, 38(5):1021-1029.
130. Woodberry K.A., Seidman L.J., Giuliano A.J., Verdi M.B., Cook W.L., McFarlane W.R. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophrenia Research 2010, 123(2-3):188-198.
131. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 2004, 67(2-3):131-142.